Sign in

Susanne Fleig

@sfleig.bsky.social
292 followers 300 following 25 posts

Nephrologist / Clinical Scientist at RWTH Aachen University Hospital. Vascular biology, tertiary lymphoid structures; outpatient clinic for CKD and hypertension; ultrasound instructor DEGUM2, renal nutrition

PostsRepliesMedia
Reposted by Susanne Fleig
International Society of Renal Nutrition and Metabolism @isrnm-social.bsky.social · 03/08/2026
We've reopened registration for a small number of people at the Renal TNT Course at ICRNM 2026! 📅 September 15-16, 2026 📍 Berlin, Germany More about interactive Renal TNT course: www.isrnm.org/tnt Register: icrnm.aey-congresse.de/registration... Don't wait - places are (very) limited!
021
Reposted by Susanne Fleig
International Society of Renal Nutrition and Metabolism @isrnm-social.bsky.social · 10/08/2026
Can nutrition help slow the progression of chronic kidney disease? Join healthcare professionals from around the world in Berlin to discuss the future of renal nutrition at #ICRNM2026. Berlin, Germany | September 15-19, 2026 Explore the full program and register: icrnm.aey-congresse.de
022
Susanne Fleig @sfleig.bsky.social · 31/07/2026
Coming up soon: icrnm.aey-congresse.de the XXI. International Congress on Renal Nutrition and Metabolism 2026 in Berlin! Best meeting worldwide on renal nutrition! Check out our fantastic program! :-) Please share, register and attend! #ISRNM #renalnutrition #nephsky
icrnm.aey-congresse.de
start - ICRNM
000
Reposted by Susanne Fleig
Petrova Lab – Vascular and Tumor Biology @petrovalab.bsky.social · 12/05/2026
Our new paper is out!
0154
Reposted by Susanne Fleig
Joel Topf @kidneyboy.bsky.social · 25/02/2026
This is what I'm talking about regarding the anti-iron bias among the ESA pushers writing the guidelines.
152
Reposted by Susanne Fleig
Makinen lab - Lymphatic Biology and Pathology @taijamakinenlab.bsky.social · 25/02/2026
Registration open for Seeon Angioscience Conference - hope to see many of you there!
053
Reposted by Susanne Fleig
Nature Portfolio @natureportfolio.nature.com · 14/01/2026
Nature outlines how scientists are deploying an array of technologies that are making a vaccine against all varieties of influenza seem more achievable. #immunosky #medsky 🧪
go.nature.com
A universal flu vaccine has proved challenging — could it finally be possible?
Scientists are deploying an array of technologies that are making a vaccine against all varieties of influenza seem more achievable.
1184
Reposted by Susanne Fleig
Bong-Ihn Koh @bikohcello.bsky.social · 05/12/2025
postdocs.yale.edu/posts/2025-1... The Koh Lab is hiring!! Please reach out to join our newly established lab as a postgraduate associate! Come help us write the first exciting chapter of our (hopefully epic) saga! #CraniofacialBM #HSCniche #Vascularbiology #Immunology #YaleStemCellCenter #YaleCMED
postdocs.yale.edu
Postgraduate Associate – Koh Lab, Yale Stem Cell Center, Department of Comparative Medicine, Yale School of Medicine
0105
Reposted by Susanne Fleig
Robert Koch-Institut @rki.de · 04/12/2025
Der Beginn der Grippewelle deutet sich an. Die aktuellen Daten im ARE-Wochenbericht zeigen, dass die ans RKI übermittelten Influenza-Fälle in den letzten zwei Wochen deutlich angestiegen sind. Personen die zur Risikogruppe gehören und bisher nicht geimpft sind, sollten dies nachholen. 👉 www.rki/are
Grafik mit blauem Rahmen und hellblauem Hintergrund. Text: „Schon gegen Grippe geimpft? Der Beginn der Grippewelle deutet sich an“. Rechts unten eine Illustration mit zwei Personen: eine Person im gelben Oberteil hält sich den Hals, daneben/hinter ihr eine Person im grünen Oberteil niest in ein Taschentuch. Unten steht: „Robert Koch-Institut“.Grafik mit blauem Hintergrund. Überschrift: „Aktuelle Situation“. Text: „Die Aktivität akuter Atemwegserkrankungen ist auf Bevölkerungsebene und im ambulanten Bereich gestiegen und liegt auf einem moderaten bzw. hohen, aber nicht unüblichen Niveau. Die Zahl schwer verlaufender Atemwegserkrankungen ist weiter niedrig. Das ARE-Geschehen wird seit mehreren Monaten hauptsächlich durch die Zirkulation von Rhinoviren und SARS-CoV-2 bestimmt.“ Darunter ein Kasten mit Glühbirnen-Symbol und Text: „Die Influenza-Positivenrate ist in den letzten zwei Wochen deutlich angestiegen, der Beginn der Grippewelle deutet sich an. Es zirkulierten bisher hauptsächlich Influenza A(H3N2)- und A(H1N1)pdm09-Viren.“ Unten steht: „Robert Koch-Institut“.Grafik mit blauem Hintergrund und einem runden Symbol (Globus mit Mauszeiger). Text: „Informationen zu Akuten Atemwegserkrankungen und zur aktuellen Situation findet ihr unter: rki.de/are“. Darunter ein weißer Kasten mit Überschrift „Etwas gelernt?“ und den Optionen „Liken“, „Reposten“, „Teilen“, „Speichern“. Unten steht: „Robert Koch-Institut“.
911444
Reposted by Susanne Fleig
ChemBioHub - Huber Lab @chembiohub.bsky.social · 06/11/2025
New in @science.org 🧬 What if an enzyme you thought you knew turned out to control metabolism in a completely new way? We found that NUDT5 acts as a molecular handbrake on purine synthesis, reshaping how cells make DNA building blocks and respond to cancer drugs. www.science.org/doi/10.1126/...
science.org
A non-enzymatic role of Nudix hydrolase 5 in repressing purine de novo synthesis
Folate metabolism is intricately linked to purine de novo synthesis through the incorporation of folate-derived one-carbon units into the purine scaffold. By investigating chemical and genetic depende...
22111
Reposted by Susanne Fleig
Petrova Lab – Vascular and Tumor Biology @petrovalab.bsky.social · 06/11/2025
❣️New in @JExpMed Proud to have contributed to the work of Cornelia Halin’s lab @ETH_en ! Single-cell & 3D imaging reveal unexpected diversity of human afferent lymphatic vessels including unique CD24⁺ valve LECs and key differences from mouse skin. rupress.org/jem/article/...
rupress.org
Transcriptomics- and 3D imaging–based characterization of the lymphatic vasculature in human skin | Journal of Experimental Medicine | Rockefeller University Press
This study reveals how the structure and cellular morphology of human dermal afferent lymphatic vessels differ from the current, primarily mouse tissue–bas
053
Reposted by Susanne Fleig
Anand Vaidya @anandvaidya17.bsky.social · 07/09/2025
academic.oup.com/ajh/advance-...
academic.oup.com
Is it time to retire confirmatory testing for primary aldosteronism?
Abstract. Primary aldosteronism(PA) is the most common endocrine hypertension. For decades, PA diagnosis has required proving non-suppressibility of aldost
072
Reposted by Susanne Fleig
American Journal of Hypertension @amjhypertension.bsky.social · 07/09/2025
#WeekendReads Long term mortality after Renal Artery Stenting 🔗 academic.oup.com/ajh/article/... 🔓 #EditorsChoice #Free
academic.oup.com
Long-Term Mortality After Renal Artery Stenting in Patients With Severe Atherosclerotic Renal Artery Stenosis and High-Risk Clinical Manifestations
AbstractBACKGROUND. Atherosclerotic renal artery stenosis is a risk factor for cardiovascular death. Observational studies support the benefit of renal rev
032
Reposted by Susanne Fleig
ASN Publications @asnpublications.bsky.social · 07/09/2025
Kidney dysfunction was diagnosed at 5-months postpartum in 12% of patients who had gestational diabetes mellitus. Read more in #ASNCJASN kidney.pub/CJASN0802
041
Reposted by Susanne Fleig
ASN Publications @asnpublications.bsky.social · 06/09/2025
New in #ASNJASN and at #Hypertension25: In a randomized, double-blind, placebo-controlled trial, Baxdrostat reduced systolic blood pressure in patients with CKD and uncontrolled hypertension. Read more about its safety and efficacy in patients with CKD here: kidney.pub/JASN0849
096
Reposted by Susanne Fleig
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 05/09/2025
If you are a nephrology or kidney disease or renal professional or interested in the field - make sure you have liked/followed/pinned the nephrology feed bsky.app/profile/did:... Thanks again to @richardferro.xyz for creating & updating this! It’s a one-stop shop for nephrology needs #NephSky
22511
Susanne Fleig @sfleig.bsky.social · 05/09/2025
Should you, too, feel like your brain is shrinking during the winter: here is why! 👇 (now, how closely related are we really to shrews!)
020
Reposted by Susanne Fleig
Hans-Joachim Anders @hjanders.bsky.social · 16/08/2025
Now open access in @ndt-era.bsky.social Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: Biological challenges and clinical implications 🧐 Clinical implementation of anti-slit diaphragm antibody testing = precision dx and tx in podocytopathies ▶️ academic.oup.com/ndt/article/...
0188
Reposted by Susanne Fleig
Hellmut Augustin @hellmutaugustin.bsky.social · 14/07/2025
Spread the word: The European Center for Angioscience @uniheidelberg.bsky.social continues to grow: We have openings for 2 additional Junior Group Leader positions. Get in touch with us if you are ready to start your own lab. See also corresponding ad in @nature.com: www.nature.com/naturecareer...
01718
Reposted by Susanne Fleig
Makinen lab - Lymphatic Biology and Pathology @taijamakinenlab.bsky.social · 08/06/2025
Exciting days ahead at the Wihuri Research Institute @wrihelsinki.bsky.social as we host #WRISymposium and #EVBOSummerSchool next week in Helsinki. Looking forward to inspiring talks and scientific exchange with the #VascularBiology community! wri.fi/research-act... evbo.org/index.php/ev...
wri.fi
Wihuri Research Institute Symposium 2025 - Wihuri Research Institute
Since 2013, the Wihuri Research Institute (WRI) has been organizing the annual WRI Symposium, providing a platform for researchers and students to share knowledge and insights in cardiovascular resear...
084
Reposted by Susanne Fleig
ibidi GmbH @ibidicells.bsky.social · 28/05/2025
We also congratulate Dr. Laetitia Préau from Karlsruhe Institute of Technology (KIT) and Dr.Tore Bleckwehl from Uniklinik RWTH Aachen for their outstanding presentations @cpi-exstra.bsky.social @sfb1531.bsky.social @sfleig.bsky.social #PCVB2025
033
Reposted by Susanne Fleig
ibidi GmbH @ibidicells.bsky.social · 28/05/2025
🔬 Congrats to the 2025 #GfMVB Award Winners! 🏆 Proudly #sponsored by ibidi at “Perspectives in Cardiovascular Biology” Conference🫀 🏅Emerging Scientist: Dr. Haaglim Cho from @mpi-hlr.bsky.social 🏅Young Investigator: Dr. Julian Wagner from Universitätsmedizin Frankfurt 🔗https://zurl.co/IAJmC
133
Reposted by Susanne Fleig
Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 03/05/2025
Resolution of steatohepatitis without worsening of fibrosis occurred in 62.9% in the semaglutide group & in 34.3% in the placebo group. Reduction in liver fibrosis without worsening of steatohepatitis was reported in 36.8% in the semaglutide group & in 22.4% in the placebo group tinyurl.com/338u24b2
042
Reposted by Susanne Fleig
markusathome @markusathome.bsky.social · 02/05/2025
Our Friday-Webinar with @christ-crain.bsky.social ! We talk about diagnosis and treatment of arginine vasopressin deficiency with our expert in german language! youtu.be/jSl5K0aRTvs?...
youtu.be
Vasopressin-Mangel (ehemalig Diabetes Insipidus) - Prof. Dr. Mirjam Christ-Crain (Basel, Schweiz)
YouTube video by MARKUS at HOMe
063
Reposted by Susanne Fleig
Kidney International @kidneyint.bsky.social · 28/04/2025
B cell-derived exosomal miR-483-5p and its potential role in promoting kidney function loss in IgA nephropathy doi.org/10.1016/j.kint.2025.03.019 #OpenAccess #MedSky #NephSky #SkyNeph #IgAN #IgAnephropathy
022
Reposted by Susanne Fleig
Academic Europe @academiceurope.bsky.social · 04/04/2025
Job - Alert 🚑 🩺 Full Professorship for Nephrology Deadline: 2025-05-03 Location: Switzerland, Bern www.academiceurope.com/job/?id=7332 #hiring #Nephrology #medicine #biomedicine #Leadership #professor #director
academiceurope.com
Academic Europe - Full Professorship for Nephrology
002
Reposted by Susanne Fleig
SFB 1531 @sfb1531.bsky.social · 05/04/2025
Congrats to Maria Dekrolia, Nivethitha Manickam, Leah Vanicek, and Sofia de la Puente Secades for receiving the Aletta Jacobs Award at the PCVB Meeting 2025 in Frankfurt! A well-deserved recognition of their outstanding contributions to science. #PCVB2025 #AlettaJacobsAward
073
Susanne Fleig @sfleig.bsky.social · 05/04/2025
Tore Bleckwehl from Aachen presenting as a finalist in the GfMVB Emerging Scientist Award session at #PCVB2025 in Frankfurt!
020
Reposted by Susanne Fleig
Rainer Kaiser @rainerkaiser.bsky.social · 05/04/2025
Excited to share the most recent work from our lab and results from two exciting cooperations: In this week's issue of @bloodjournal.bsky.social (ashpublications.org/blood/issue), Afra Anjum presents her cover story on how aging platelets gain inflammatory functions in the circulation. 1/4
194
Reposted by Susanne Fleig
NEJM.org @nejm.org · 30/03/2025
Presented at #ACC25: Lepodisiran, an extended-duration, small interfering RNA, reduced lipoprotein(a) concentrations in participants with elevated levels. Full ALPACA trial results: nej.md/4kWjJyn #MedSky @accintouch.bsky.social
A graph showing the least-squares mean percent change in the lipoprotein(a) concentration from baseline through 540 days in the efficacy analysis set, which included data from participants who received at least one dose of lepodisiran or placebo, with the exclusion of data collected from participants after discontinuation of lepodisiran or placebo or initiation of medications known to affect lipoprotein(a).
0117
Reposted by Susanne Fleig
immunoboys @immunoboys.bsky.social · 30/03/2025
During inflammation, CCL21 is down-regulated in the lymph node. Enzymes for production of oxysterols are induced and recruitment of naive/central memory cells relies more in oxysterols interacting with GPR183 (+ CCL19). in 🐭 Chen et al @cellpress.bsky.social 2025 pubmed.ncbi.nlm.nih.gov/39708807/
053
Reposted by Susanne Fleig
Joel Topf @kidneyboy.bsky.social · 30/03/2025
Finally! (Psst it was never the fluid, it was always the sodium)
43010
Reposted by Susanne Fleig
Brendon Neuen @brendonneuen.bsky.social · 29/03/2025
Cardiovascular, Kidney & Mortality Outcomes With Long-Acting Injectable & Oral GLP1-RA in T2 Diabetes An updated meta-analysis of >70,000 patients after the SOUL trial ⬇️ 14% MACE ⬇️ 14% heart failure ⬇️ 17% CKD progression ⬇️ 12% all-cause mortality diabetesjournals.org/care/article...
0115
Reposted by Susanne Fleig
Vincenza Cifarelli, PhD @cifarelliv.bsky.social · 12/03/2025
Our latest publication investigating the role of #palmitoylation in #lymphatic endothelial integrity. Big shoutout to Silvia Gonzalez-Nieves, Simon GUIGNARD and Thi Nguyen for their incredible work and dedication. 👏👏 www.sciencedirect.com/science/arti...
sciencedirect.com
Insulin regulates lymphatic endothelial integrity via palmitoylation
Lipid metabolism plays a critical role in lymphatic endothelial cell (LEC) development and vessel maintenance. Altered lipid metabolism is associated …
154
Reposted by Susanne Fleig
Pierre-Paul Axisa @ppaxisa.bsky.social · 25/03/2025
A bit slow on the draw, but our manuscript phenotyping multiple sclerosis patients before and after anti-CD20 treatment is out in JCI! Using scRNAseq we show that there is a myeloid expansion in both blood and CSF. In blood there's a ubiquitous TNF-NFkB signature and monocytes make more TNF post-Tx
262
Reposted by Susanne Fleig
haysamrady @sodatroubles.bsky.social · 21/03/2025
Effect of albumin treatment duration on response rates and outcomes in patients with cirrhosis and acute kidney injury #nephsky www.sciencedirect.com/science/arti...
sciencedirect.com
Effect of albumin treatment duration on response rates and outcomes in patients with cirrhosis and acute kidney injury
Guidelines recommended volume expansion with albumin for 48 hours for patients with cirrhosis and acute kidney injury (AKI) to correct hypovolemia and…
051
Reposted by Susanne Fleig
Dr. Smita Divyaveer, MD, DM Nephrology @divyaveerssneph.bsky.social · 21/03/2025
🆕 🥇FDA approved therapy for C3 Glomerulopathy Iptacopan : inhibitor of the alternative complement pathway by specifically binding to and inhibiting factor B #Hope for #kidney #disease #Great time to be in #Nephrology #Nephsky #Nephbluesky #Medsky #Medbluesky #Nephronuggets
064
Reposted by Susanne Fleig
Atul Gawande @agawande.bsky.social · 13/03/2025
Nothing will kill more children than the ongoing decimation of CDC, NIH, and USAID work to lift vaccine uptake in the US and world. Child survival rose 75% in the last 50 years. Vaccines account for 40% of that. Measles vax alone was 60% of the benefit. www.thelancet.com/journals/lan...
thelancet.com
Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization
Since 1974 substantial gains in childhood survival have occurred in every global region. We estimate that EPI has provided the single greatest contribution to improved infant survival over the past 50...
5135111679
Reposted by Susanne Fleig
Kalev Freeman @uvmtraumalab.bsky.social · 15/03/2025
Endothelial integrin acetylation regulates vascular barrier function. This suggests new therapeutic possibilities for controlling vascular permeability in disease states. #Endothelium #VascularBiology #ImmunoSky #MedSky 🧪
082
Reposted by Susanne Fleig
American Journal of Hypertension @amjhypertension.bsky.social · 13/03/2025
Mineralocorticoid Receptor in Endothelial Cells Contributes to Vascular Endothelial Growth Factor Receptor Inhibitor-Induced Vascular and Kidney Damage academic.oup.com/ajh/article/... 🔒
095
Reposted by Susanne Fleig
Guille Luxán @gluxan.bsky.social · 11/03/2025
What determines whether an endothelial cell becomes arterial? @saradv.bsky.social and her team had a crack at it in @elife.bsky.social and have identified a list of genetic enhancers crucial for this -> elifesciences.org/articles/102... Congratulations on this very cool study 💃🏻💃🏻 I really liked it!
elifesciences.org
Evaluating the transcriptional regulators of arterial gene expression via a catalogue of characterized arterial enhancers
Identification and characterization of enhancers for eight key arterial genes reveal transcription factors associated with different aspects of endothelial gene expression specificity and provide a to...
1189
Susanne Fleig @sfleig.bsky.social · 09/03/2025
An alle Nephrologen und Nephrologie-Sympathisanten- macht mit bei #NephMadness! Tippspiel ohne WM. 🙂 👇
020
Reposted by Susanne Fleig
Europe PMC @europepmc.org · 28/02/2025
Looking for the latest preprints in the #LifeSciences ? Europe PMC indexes content from 24 #preprint servers, including bioRxiv, Research Square, medRxiv and more!! 🔎 Start exploring over 907,000 preprints in one database: europepmc.org/search?query=SRC%3A%2a%20AND%20%28SRC%3APPR%29&page=1
Stacked area chart showing the cumulative number of preprints indexed by Europe PMC from 2020 to 2025. The x-axis represents the years, while the y-axis represents the cumulative number of preprints, reaching over 900,000 by 2025. Different colours represent various preprint servers, including Research Square (largest share), bioRxiv, Preprints.org, medRxiv, PsyArXiv, Authorea Preprints, SSRN, and Others. The chart highlights the steady growth of preprint publications over time.
02216
Reposted by Susanne Fleig
PEnghard @penghard.bsky.social · 02/03/2025
This works in case pubmed stays down… and it looks like a cool alternative anyway! #nephsky #science europepmc.org
europepmc.org
Europe PMCHome - Europe PMC
Europe PMC is an archive of life sciences journal literature.
02817
Susanne Fleig @sfleig.bsky.social · 01/03/2025
Hi #nephsky, is pubmed.gov gone or just not working today/ from overseas anymore?
pubmed.gov
PubMed
PubMed® comprises more than 37 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full text content from PubMed Central a...
410
Reposted by Susanne Fleig
American Journal of Kidney Diseases @ajkd.bsky.social · 01/03/2025
#NephMadness 2025: Green House Region buff.ly/xEPnVQO Teams - Tubular Toxins - Oxalate Offenders Expert: @lawdishu.bsky.social Writers: Rachel Khan & Ethan Downes Execs: @kidneywars.bsky.social & Elena Cervantes
buff.ly
#NephMadness 2025: Green House Region
Submit your picks! | @NephMadness | @nephmadness.bsky.social | NephMadness 2025 Selection Committee Member: Linda Awdishu @LAwdishu @lawdishu.bsky.social Linda Awdishu is a Professor and Division H…
076
Reposted by Susanne Fleig
American Journal of Kidney Diseases @ajkd.bsky.social · 01/03/2025
#NephMadness 2025: The PodCrawl buff.ly/p3xR3cg Podcasts: - @thecurbsiders.bsky.social - Life as a Nephrology Professional @nkf-professionals.bsky.social - GN in Ten - @rheummadness.bsky.social - @freelyfiltered.bsky.social - Poison Lab - Nephron Segment - Kidney Chronicles
buff.ly
#NephMadness 2025: The PodCrawl
Submit your picks! |  @NephMadness |@nephmadness.bsky.social | NephMadness 2025 Over the next couple of weeks, NephMadness 2025 will be popping up on some great podcasts.  Keep your eyes and ears o…
01511
Reposted by Susanne Fleig
Baptiste Lacoste @blacoste.bsky.social · 28/02/2025
The #BloodBrainBarrier is again on the front page 🤩
doi.org
Glycocalyx dysregulation impairs blood–brain barrier in ageing and disease - Nature
Disruption of mucin-domain glycoprotein expression and function in the endothelial glycocalyx are associated with ageing and Alzheimer’s disease, leading to dysregulated blood–brain barrier function.
0297
Reposted by Susanne Fleig
ASN Publications @asnpublications.bsky.social · 26/02/2025
A novel diet score, representing its inflammatory potential, was associated with a higher risk of developing CKD. Reducing consumption of pro-inflammatory diet may be a strategy to prevent CKD. bit.ly/CJASN0635 #ASNCJASN
031
Reposted by Susanne Fleig
The puppies Penn & Teller, and Richard @rdaily.medsky.social · 07/02/2025
Do I have the flu? #Medsky #EMedsky
1125233